SEM EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
SEM's ev/ebitda is higher than 65% of the last 10 years.
EV/EBITDA History
SEM EV/EBITDA by year
Yearly range of SEM’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 5.7 to 15.4, averaging 9.0.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 9.6 | 10.1 | 10.7 | 9.7 |
| 2025 | 10.4 | 12.9 | 15.4 | 10.4 |
| 2024 | 8.5 | 9.5 | 11.9 | 11.9 |
| 2023 | 8.5 | 9.8 | 11.2 | 8.7 |
| 2022 | 6.5 | 8.6 | 10.5 | 10.4 |
| 2021 | 5.7 | 7.4 | 9.4 | 7.1 |
| 2020 | 7.4 | 8.3 | 9.3 | 8.4 |
| 2019 | 6.4 | 7.9 | 8.9 | 8.7 |
| 2018 | 6.6 | 7.8 | 8.7 | 6.6 |
| 2017 | 7.8 | 8.1 | 8.5 | 8.0 |
| 2016 | 7.5 | 7.8 | 8.2 | 7.8 |
Get notified when SEM EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is SEM EV/EBITDA High or Low Right Now?
Select Medical Holdings Corporation's EV/EBITDA is currently 9.7, which is above average relative to its 10-year historical range. The 10-year median EV/EBITDA for SEM is approximately 8.5. See all SEM valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.